Neuroscience Webinars & Conferences
International Summit On Depression, Anxiety And Stress Management
12th International Conference On Stroke, Neurology And Cerebrovascular Diseases
16th World Summit On Alzheimer’s Disease, Dementia Care Research And Awareness
14th International Conference On Neurology And Neuromuscular Disorders
15th international Conference On Alzheimers Disease & Dementia
7th International Conference On Central Nervous System Disorders & Therapeutics
6th International Conference On Pediatrics, Neonatology And Pediatric Surgery
2nd International Conference On Neurology And Neurorehabilitation
10th International Conference On Stroke And Cerebrovascular Diseases
4th Head And Neck Conference: The Multidisciplinary Approach
2nd European Conference On Dementia, Alzheimers And Neurological Disorders
31st International Conference On Public Mental Health And Neurosciences
6th International Conference On Central Nervous System Disorders & Therapeutics
15th International Conference On Neuroscience And Dementia
14th International Conference On Neurosurgery And Neuroscience
17th World Congress On Vascular Dementia And Neurodegenerative Diseases
2nd International Conference On Parkinsons And Neurodegenerative Diseases
19th International Conference On Nephrology, Urology And Therapeutics
32nd International Conference On Neurology And Cognitive Neuroscience
27th International Conference On Neuropharmacology And Neurochemistry
Euro Psychiatry 2021: 31st Euro Congress on Psychiatrists and Psychologists is scheduled to be held during April 05-06, 2021 Webinar. Euro Psychiatry 2021 aims at providing a platform to share their state of art, exchange and ideas, views, experiences, research and technologies of scientists which would cover the most important sessions of Psychiatry and Psychology. We welcome all the Participants to this esteemed Webinar as this event will be the best amalgamation of academic and research involving every aspect of Mental Health well-being. Euro Psychiatry Webinar brings together Psychologists, Scientists, Professors, Neuropsychiatrists, Researchers, Mental health professionals, spiritual healers, Healthcare professionals, Young researchers and many other key people related to the fields of Psychology, Psychiatry and Health care sectors to be a part of this esteemed Euro Psychiatry 2021 Conference. The global psychiatrist market was valued at $795.1 billion. North America was accounting for $380.1 billion or 0.4% of the global market. And the USA was the largest country which is accounting for $318.8 billion or 0.4% of the global psychiatrist market. Likewise, according to some studies, the global schizophrenia market is estimated to reach US$10.43 billion in 2023, growing at a CAGR of 3.69%, for the period spanning from 2018 to 2023. China’s demand for Mental Illness Drugs has been growing at a fast pace in past few decades. In the next decade, both production and demand will continue to grow for psychiatric drugs.
Scientific Sessions: Psychiatry vs. Psychology, Psychiatric Disorders, Child Psychology, Women’s Mental Health and Disorders, Psychiatry Conferences in 2021, Anxiety Disorders, Bipolar and Schizophrenia, Autism and ADHD, Clinical Neuropsychology, Addiction Psychiatry, Behavioral Neuroscience, Conferences and Meetings on Psychiatry, Social Psychology, Psychopharmacology, Pharmacotherapy, Cognitive Neuroscience, Psychopathology and Psychopathy, Psychoanalysis and Psychometrics, Early Diagnostics and Interventions, Mental Illness and Awareness, Neuropsychiatry, Geriatric Psychiatry.
Neurophysiology 2021: 25th International Conference on Neurology and Neurophysiology is scheduled to be held during April 05-06, 2021 Webinar. Neurophysiology Conferences will give a perfect platform for sharing and developing innovative ideas on the latest developments and future perspectives in the field of neurology and neurophysiology for the treatment of various Neurological disorders. Attending Neurophysiology 2021 is an investment in your career growth. It’s the best way to express your passion towards the Neurology research and update your skills and enhance your knowledge. Neurophysiology 2021 participants include Professors, Researchers, Physicians, Business Delegates, Scientists, students all over the world. The goal of the Neurophysiology Meeting is to provide you with a rare opportunity to build on what you already know in the research and development of new therapies and techniques and accelerate efforts to enhance health and well-being. European pharmaceutical industry spent approximately €3.3 billion on brain research per year, corresponding to 79% of the total funding for brain research in Europe. Research on neurodegenerative diseases, a subset of neurological diseases, was supported with EUR 401 million, with priority on Alzheimer’s disease and Parkinson’s disease. Research on neuropsychiatric diseases such as depression or schizophrenia has been supported with EUR 283 million. In Europe overall, neurological damage accounts for 40% of people who are severely disabled and who require daily help.
Scientific Sessions: Neurology & Neurogenesis, Neurophysiology & Clinical Neurophysiology, Neuroimaging & Neurointensive Care, Neurology & Neurophysiology Conferences, Behavioral Neurology & Neurorehabilitation, Advancements in Neurology, Neuropharmacology & Neurochemistry, Neuronal Functions and Disorders, Neuroplasticity & Neuroepidemiology, Neuroradiology & Neuro Oncology, Paediatric Neurology, Neuroimmunology, Neuro-Opthalmology.
Brain Disorders 2021: 10th International Conference on Brain Disorders and Therapeutics is scheduled to be held during May 24-25, 2021 Webinar. Brain is the most complex and sensitive organ in the body. Minute damages to the brain might cause devastating consequences leading to several brain disorders. It may occur in early childhood causing developmental disorders such as autism and dyslexia. Brain Disorders 2021 is a global platform to discuss and learn about early detection as well as treatment, care based on Professional standards, and increased research to accomplish cure for all Brain Disorders. Brain Disorders 2021 is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. The global market for Alzheimer’s disease reached $10.2 billion in 2012. The market is expected to decrease to $9.5 billion in 2017 for a CAGR of -1.5%. The Alzheimer's Association funds independent investigators worldwide, they have awarded over $335 million to more than 2,250 projects. The global cost of Alzheimer’s and dementia is estimated to be $605 billion, which is equivalent to 1% of the entire world’s gross domestic product. Aggregate Cost of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and Other Dementias: Medicare $113 Billion, Medicaid $41 Billion, Out of pocket $44 Billion, Other $29 Billion.
Scientific Sessions: Brain Disorders, Brain Cancer & Tumors, Neurological Disorders, Neuroimmunology, Neurosurgery, Brain Disorders Conference, Traumatic Brain Injury, Mental Retardation, Neuroinflammation, Pathophysiology of Brain Disorders, Cerebrospinal Complications, Brain Complications, Neurodegeneration & Aging Disorders, Brain Disorders 2021, Pediatric Neurology, Neuropharmacology, Neurology of Brain, Novel Treatment Strategies, Addiction & Brain Disorders, Analysis, Neuroscience Conferences, Assessment And Diagnosis of Brain Disorders, Stem Cell Therapies, Neuro Oncology.
Neurology Congress 2021: 35th European Neurology Congress is scheduled to be held during June 14-15, 2021 at London, UK. Neurology Congress 2021 is organised to discuss the specific topics in the field of Neuroscience like Clinical Neurophysiology, Neurosurgery, Neuro Muscular Disorders, Neuro Infectious Diseases, Pediatric Neurology, Neuropathology, Brain Tumor and Neuro-oncology and many more. Neurology Conferences provides the perfect platform for Neurologists & Directors, Neuroscientists, Physicians, Neurosurgeons, Health care professionals, Psychiatrist, researchers, professors, scientific communities, delegates, students, business professionals and executives to discuss and learn about novel findings in Neuroscience. The global neuroscience market is expected to reach USD 100 million by 2023 growing at a 12% CAGR over the forecast period 2017-2023. According to the latest survey conducted by WHO, it is revealed that Neurological Disorders encompassing Stroke, Alzheimer & Dementia, Epilepsy and many more accounts for more than 12% of deaths worldwide on an average and it is also predicted that the number of disability –adjusted life years vanished due to Neurological disorders are expected to accelerate from 95 million globally in 2015 to 103 million by 2030.
Scientific Sessions: Neurology, Clinical Neurophysiology, Neurosurgery, Central Nervous System, Pediatric Neurology, Neuromuscular Disorders, Psychiatry and Psychology, Spine and Spinal Disorders, Neurology Conferences, Neurogenetic and Neurometabolic Disorders, Neuropharmacology, Nursing and Neuroscience, Neuroimmunology and Neuroinfections, Neurology Meetings, Brain Tumor and Neuro-oncology, Neuroplasticity & Neurorehabilitation, Neuropathology, Neurology Conferences 2021, Neuro Cardiology & Strokes, Critical Care Neurology, Clinical Trails & Case Reports, Neuroscience Conferences.
Psychosomatic Medicine 2021: 38th International Conference on Psychiatry and Psychosomatic Medicine to be held during July 05-06, 2021 in Valencia, Spain. Psychosomatic Medicine 2021 is an annual meeting of Psychiatrists as well as Psychologist committees to discuss the future of the Psychology and Psychiatry in terms of collaboration, structures and organizational development and advances of Psychiatry and Psychological syndromes. Psychological challenges define and deliberates the increasing global public health importance of common psychiatry disorders for example dementia, epilepsy, headache disorders, multiple sclerosis, neurodegeneration, neurological disorders like stroke, traumatic brain injuries and several other brain complications during this Covid19 pandemic situation. About 14% of the global burden of disease has been attributed to neuropsychiatric disorders, as by 2020, it is estimated to be that the burden of a mental disorder will have to be increased to 15 % of the Disability Adjusted Life Years, which is termed to be (DALYs). Mostly due to the regularly disabling nature of depression and other common mental disorders, alcohol-use and psychosis. Such estimates have drawn helpfulness to the importance of mental disorders for public health. The problem of mental disorders is likely to have been misjudged because of inadequate appreciation of the connectedness between psychological illness and other health disorders.
Scientific Sessions: Psychosomatic Disorders, Addiction Psychiatry, Psychosomatic Treatment, Consultation-liaison Psychiatry, Mental Health, Psychopharmacology, Psychotherapy, Neuroscience, Psychology & Psychiatry, Psychosomatic Conferences 2021 Europe, Child and Adolescent Psychiatry, Adult and Geriatric Psychiatry, Stress-Anxiety and Depression, Psychiatric Nursing, American Psychosomatic Society Conferences, Self-harm and Suicide Prevention, Sexual Psychiatric Disorder, Pediatric Nursing, Yoga & Meditation, Healthcare.
Epilepsy 2021: 7th International Conference on Epilepsy and Treatment scheduled to be held on July 26-27, 2021 at London, UK. Epilepsy 2021 includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. Epilepsy 2021 is a platform to discuss and learn about the latest advancements in the field of Epilepsy Treatment as the world’s consideration turned regarding the urgency of novel Epilepsy treatment. This Summit is a best Platform to share or explore their insight in the field of Epilepsy & Treatment, Neurology, Neuroscience, Neurophysiology, Neuropharmacology, Epilepsy professionals, researchers in Epilepsy, professors, scientific communities, Epilepsy Foundations, Epilepsy Diagnosis Centres, delegates, students, business professionals and executives to discuss and learn about novel therapeutics for treatment of Epileptic seizures. North America is the largest market for anti-epileptic drugs manufacturing, accounting for 33.9% of the global market. It is followed by the Asia-Pacific region and Western Europe. Eastern Europe is expected to witness the fastest market growth, with CAGR of 5.4% through 2022. We welcome you to go along with us at the Epilepsy 2021, where we guarantee you to have a huge involvement with researchers from all around the globe.
Scientific Sessions: Neurobiology of Epilepsy, Epilepsy in Paediatrics, Epilepsy Devices, Epilepsy & Pregnancy, Prevention & Management of Epilepsy, Epilepsy Conferences, Non-Surgical Treatment of Epilepsy, Ketogenic Diet, Herbal Treatments for Epilepsy, Epilepsy Treatment Conference, Epilepsy Surgery, Advanced Epilepsy Diagnosis Assessment, European Epilepsy Conference, Epilepsy Case Reports, Homeopathic Treatment of Epilepsy, Immunomodulatory Treatments in Epilepsy, Metacognitive beliefs in Epilepsy, Cannabinoids in Treatment of Resistant Epilepsy, International Epilepsy Congress, Cognitive Disorders of Epilepsy, Seizure First Aid and Safety, SUDEP: Sudden Unexplained Death in Epilepsy, Highly Marketed and Used Drugs of Epilepsy, Epilepsy Congress.
Stroke Congress 2021: 11th International Conference on Neurological Disorders & Stroke is scheduled to be held during August 23-24, 2021 at Vienna, Austria. A stroke, can be called as a brain stroke, occurs when something blocks blood supply to part of the brain or when a blood vessel in the brain bursts. Stroke Congress 2021 is organised to discuss the specific topics in the field of Neurology like Neurosurgery, Management of Stroke, Neuro Oncology, Stroke and Mental Health and many more. Stroke Conference provides the perfect platform for Neurologists, Psychiatrists, Neurosurgeons, Neuroscientists, Clinical Neurologists, Neurosurgeons, Spine Specialists, Cognitive Behavioral Therapists, Health care professionals, researchers, professors, scientific communities, delegates, students, business professionals and executives to discuss and learn about novel findings in Neuroscience. Increasing number of neurological disorders across the globe will drive the neurological disorders market growth in the upcoming years. According to World Health Organization (WHO), neurological disorders accounted for 6.3% of global disability-adjusted life-years. Global Neurovascular Devices Market is set to surpass USD 3 billion by 2025; according to a new research report by Global Market Insights. Also, the volume of neurovascular devices sold in 2018 accounted for around 1,020 thousand units and the number is poised to grow substantially over the forecast period.
Scientific Sessions: Stroke, Neurosurgery, Management of Stroke, Neuro Oncology, Stroke and Mental Health, Stroke Conferences, Paediatric Stroke, Stroke Conferences Europe, Cerebrovascular Disorders, Stroke Conferences 2021, Stroke and Cerebral Haemorrhage, Brain Tumor, Stroke Events, Central Nervous System, Neuroscience Conferences, Neurology and Neurological Disorders, International Stroke Conference 2021.
Alzheimer’s 2021: 16th World Summit on Alzheimer’s disease, Dementia Care Research and Awareness is scheduled to be held during August 23-24, 2021 at Vienna, Austria. The Alzheimer’s disease is currently ranked as the sixth leading cause of death in the United States, but recent estimates indicate that the disorder may rank third, just behind heart disease and cancer, as a cause of death for older people. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities. Dementia ranges in severity from the mildest stage, when it is just beginning to affect a person’s functioning, to the most severe stage, when the person must depend completely on others for basic activities of daily living. The Global Alzheimer’s Drugs Market by Drug Class (Cholinergic, Memantine, and Combined Drug) and by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024”. According to the report, global Alzheimer’s Drugs Market was valued at approximately USD 3.64 billion in 2017 and is expected to generate revenue of around USD 5.66 billion by end of 2024, growing at a CAGR of around 8% between 2018 and 2024.
Scientific Sessions: Dementia, Alzheimer’s Disease, Dementia and Ageing, Vascular Dementia, Geriatrics Dementia and Cognitive Disorders, Alzheimer's Association Conferences, Animal Models in Dementia, Amyloid Protein in Alzheimer’s and Dementia, Dementia Care Management, Dementia Nursing, Recent Advancement in Treating Dementia.
Parkinsons Congress 2021: 7th World Congress on Parkinsons & Huntingtons Disease is scheduled to be held during September 06-07, 2021 at Berlin, Germany. Parkinson’s Congress 2021 will help you to better understand how Neurological syndrome develop the Brain Disorders and other disease issues with a strong scientific, clinical and commercial mind set and how innovative scientific techniques, emerging technologies and innovative devices can transform Parkinson’s and Huntington’s patients to normal. Parkinson’s Congress provides the perfect platform for Neurology, Pharmaceutical, Brain surgery, Clinical Research, Neurological professionals, researchers, professors, scientific communities, delegates, students, business professionals and executives to discuss and learn about novel findings in Neurological Sciences. The global Parkinsons and Huntington’s market was worth $4.0 billion by 2017 and will reach $7.0 billion in 2025, growing at 6.0%. The global Addiction Treatment market is experiencing constant growth due to the worldwide increase in life expectancy, as well as the increasing incidence of chronic and infectious diseases. The steadily increasing demand for innovative drugs has thus triggered a significant rise in R&D investments in the Parkinson’s and Huntintons Treatment industry.
Scientific Sessions: Parkinson Disease, Epidemiology of Parkinson’s, Parkinson’s Conferences Neuromuscular Disorders, Huntington’s Disease, Risk Factors of Parkinson’s Disease, Pathophysiology and Pharmacology, Diagnosis for Parkinson’s Disease, Parkinson’s Disease: Complications, Mitochondrial Dysfunction, Insights and Therapeutics: Parkinson’s Disease, Managing Life with Parkinson’s Disease, Neurosurgery, Free Radicles and Aging in Parkinson’s, Novel Therapeutics, Clinical Trials in Parkinson’s Diseases, Psychology of Parkinson's Patients , Chemotherapy for Parkinson's Psychological Disorders, Neurology Research Conferences.
Dementia Conferences | Neurology Conferences | Alzheimers Disease Events | Dementia Nursing Congress | Neurology and Neurosurgery Conferences | European Dementia Conferences | Neuroscience Conferences
Dementia 2021: 15th International Conference on Alzheimers Disease and Dementia Scheduled on September 27-28, 2021 at Ireland, Dublin. Dementia gathering can target the foremost recent and energizing developments in each facet of insanity think about that offers a noteworthy open door for agents over the world to fulfil, organize, and see new logical advancements World’s population, suffer from Neurological disorders, from Alzheimer Disease, strokes, multiple sclerosis and epilepsy to migraine, brain injuries and neuro infections, with some 6.8 million dying each year. The global Alzheimer’s sickness (AD) market value $2.9 billion in 2016 is ready to achieve $14.8 Billon, rising at a Compound Annual rate of growth (CAGR) of seventeen.5%, across the 7 Million by 2026 consistent with world information, a recognized leader in providing business info and analytics Alzheimer's disease is that the commonest style of dementia.
Scientific Sessions: Dementia, Dementia Lewy Body, Care Practice and Awareness, Ageing and Dementia, Dementia Nursing, Recent Studies & Case Reports, Alzheimer’s Disease, Alzheimer’s Clinical Trials and Studies, Novel Therapeutic Targets and Mechanisms for Treatment, International Conference on Dementia, Mental Health Conferences 2021, Amyloid Protein in Alzheimer’s and Dementia, Dementia Nursing Congress, Molecular Genetics and Biology of Dementia, Neurodegenerative Diseases, Psychiatry Mental Health Disorders, Animal Models and Translational Medicine, Alzheimers Disease Events
Psychiatry Congress 2021: 4th World Congress on Psychiatry & Psychological Syndromes scheduled during November 01-02, 2021 at Paris, France. Goal of Psychiatry Congress 2021 is to deliver an outstanding program for exchange of ideas and authoritative views by leading scientists which covers the entire spectrum of research in Psychology and Psychiatry and share the cross-cultural experiences of various treatment procedures. Psychiatry Congress 2021 is an annual meeting of Psychiatrists as well as Psychologist committees to discuss the future of the Psychology and Psychiatry in terms of collaboration, structures and organizational development and advances of Psychiatry and Psychological syndromes. About 14% of the global burden of disease has been attributed to neuropsychiatric disorders, as by 2021, it is estimated to be that the burden of a mental disorder will have to be increased to 15 % of the Disability Adjusted Life Years, which is termed to be (DALYs). Mostly due to the regularly disabling nature of depression and other common mental disorders, alcohol-use and psychosis. Such estimates have drawn helpfulness to the importance of mental disorders for public health. The problem of mental disorders is likely to have been misjudged because of inadequate appreciation of the connectedness between psychological illness and other health disorders.
Scientific Sessions: Psychiatry vs. Psychology, Psychosomatic Disorders & Psychosomatic Medicine, Child and Adolescent Psychiatry, Alzheimer’s and Dementia, Telepsychiatry, Neuropsychology and Neurodegenerative Disorders, Bipolar Disorder and Schizophrenia, Anxiety, Stress, and Depression, Sleep Disorders, Obsessive Compulsive Disorder, Women’s Mental Health and Midwifery, Addiction and Substance Use Disorders, Pharmacotherapy & Psychopharmacology, Psychopathology and Psychopathy, Psychoanalysis and Psychometrics, Early Diagnostics and Interventions, Adult and Geriatric Psychiatry, Neuroscience and Neuropsychiatry, Psychiatric and Mental Health Nursing, Mindfulness Yoga & Medication.
Neurosurgery 2021: 14th International Conference on Neurosurgery and Neuroscience are scheduled to be held during November 29-30, 2021 at Barcelona, Spain. Neurosurgery 2021 main aim is to bring Neurologists and Directors, Stroke Specialists, Neurology researchers, Neuroscientists, Specialists, Researchers, Professors, Industrial Experts, Neurosurgeons, Psychiatrist, Lecturers and Students and Neuroscience Therapists, Neurology organizations, societies and associations. Market was valued at $30 million in 2016, and is projected to reach $55 million by 2024, growing at a CAGR of 7.3% from 2016 to 2024. North America was the highest contributor to this market, with $35 million in 2016, and is anticipated to reach $63 million by 2024, registering a CAGR of 8.7%. Asia-Pacific is anticipated to reach $40 million by 2024.
Scientific Sessions: Neurosurgery, Neuroimaging and Radiology, Neuropathology, Neurosurgery Conferences in 2021, Neurogenomics, Clinical Neurophysiology, Paediatric Neurology, Neuromuscular Disorders, Spine and Spinal Disorders, Neurogenetic and Neurometabolic Disorders, Neurodegeneration and Aging Disorders, International Conference on Neurosurgery, Neurosurgery Events, Brain Mapping & Biomarkers
Neurology 2022: 31st World Congress on Neurology and Therapeutics is scheduled to be held during February 09-10, 2022 at London, UK. Neurology 2022 is organised to discuss the specific topics in the field of Neuroscience like Clinical Neurology and Neurosurgery, CNS and Brain disorders, Neuro Infectious Diseases, Pediatric Neurology, Neuropathology, Psychiatry, Psychology and Mental Health and many more. Neurology Conferences provides the perfect platform for Neurologists & Directors, Neuroscientists, Physicians, Neurosurgeons, Health care professionals, Psychiatrist, researchers, professors, scientific communities, delegates, students, business professionals and executives to discuss and learn about novel findings in Neuroscience. The global neuroscience market is expected to reach USD 100 million by 2023 growing at a 12% CAGR over the forecast period 2017-2023. According to the latest survey conducted by WHO, it is revealed that Neurological Disorders encompassing Stroke, Alzheimer & Dementia, Epilepsy and many more accounts for more than 12% of deaths worldwide on an average and it is also predicted that the number of disability –adjusted life years vanished due to Neurological disorders are expected to accelerate from 95 million globally in 2015 to 103 million by 2030.
Scientific Sessions: Neurology Insights and Innovations, CNS and Brain Disorders, Neurodegenerative Disorders, Clinical Neurology and Neurosurgery, Neuroinfections and Neuroimmunology, Neuropathology and Applied Neurobiology, Neurology Conferences, Neurotherapeutics, Diagnostics and Case Studies, Neuropharmacology and Neurogenetics, Neurology Meetings, Neurophysiology, Neuroimaging and Radiology, Psychiatry, Psychology and Mental Health, Neurology Conferences 2022, Pharmaceutical Research in CNS/Neurology, Neurological Nursing, Neuroscience Conferences.
Cognitive Neuroscience 2022: 32nd International Conference on Neurology and Cognitive Neuroscience is scheduled to be held during February 09-10, 2022 at London, UK. Cognitive neuroscience is the scientific field that is concerned with the study of the biological processes and aspects that underlie cognition, with a specific focus on the neural connections in the brain which are involved in mental processes Cognitive Neuroscience 2022 is a global platform to discuss and learn about early detection as well as treatment, care based on Professional standards, and increased research to accomplish cure for all cognitive Disorders. Cognitive Neuroscience 2022 will provide an opportunity for all stakeholders working on Alzheimer’s disease and Dementia to talk about their work. Neurocognitive disorders will congregate renowned speakers, principal investigators, experts, neurologist’s and Dementia researchers from both academia and health care industry will join together to discuss their views and research. The global market for Alzheimer’s disease reached $10.2 billion in 2012. The market is expected to decrease to $9.5 billion in 2017 for a CAGR of -1.5%. The Alzheimer's Association funds independent investigators worldwide, they have awarded over $335 million to more than 2,250 projects. The global cost of Alzheimer’s and dementia is estimated to be $605 billion, which is equivalent to 1% of the entire world’s gross domestic product. Aggregate Cost of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and Other Dementias: Medicare $113 Billion, Medicaid $41 Billion, Out of pocket $44 Billion, Other $29 Billion.
Scientific Sessions: Cognitive Neuroscience, Migraine, Dementia, Vascular Dementia, Neurodegeneration and Aging Disorders, Neurology Conferences, Neuropsychiatry, Neurology Nursing, Neuropharmaceutics, NeuroTherapeutics, Pathogenesis of Cognitive Disorders, Cognition and Behaviour, Cognitive Neuroscience 2022, Consciousness, Neuro oncology, Neurosurgery, Challenges In Neurosurgery, Cognitive Rehabilitation, Mental Health or Mental Disorders, Neuroscience Conferences, Robotic Neurosurgery, Neuroscience, Neurocognitive Disorders, Approaches for Neural Dynamics, Non-Pharmacological Management.
Major Neurology Associations:
- Acoustic Neuroma Association and ADA Disability and Business Technical Assistance Program
- Aicardi Syndrome Foundation and Alliance for Aging Research
- ALS Association and ALS Therapy Development Institute
- Alternating Hemiplegia of Childhood Foundation and Alzheimer's Drug Discovery Foundation
- Alzheimer's Association and Alzheimer's Foundation of America
- American Association on Health and Disability and American Autoimmune Related Diseases Association
- American Behcet's Disease Association and American Brain Coalition
- American Brain Tumor Association and American Cancer Society
- American Headache Society Committee for Headache Education and American Heart Association
- American Liver Foundation and American Parkinson Disease Association
- American RSD Hope Organization and American Sleep Apnea Association
- American Speech-Language-Hearing Association and American Stroke Association
- Association for Glycogen Storage Disease and Association for Science in Autism Treatment
- Attention Deficit Disorder Association and Autism National Committee
- Autism Network International and Autism Research Institute
- Autism Science Foundation and Autism Society of America
- Autism Society of America Foundation and Autism Speaks, Inc.
- Barth Syndrome Foundation , Inc and Batten Disease Support and Research Association
- Brain Aneurysm Foundation and Brain Injury Association of America, Inc.
- Brain Injury Resource Center and Brain Trauma Foundation
- Caregiver Action Network and Carter Center for Brain Research in Holoprosencephaly
- Cerebral Palsy Foundation and CHADD
- Childhood Brain Tumor Foundation
- Children's Brain Disease Foundation and Children's Brain Tumor Foundation
- Children's Hemiplegia and Stroke Association and Children's Tumor Foundation
- Christopher and Dana Reeve Foundation
- Coma/Traumatic Brain Injury Recovery Association and Compassionate Friends
- Epilepsy Foundation and Epilepsy Institute
- Fibromuscular Dysplasia Society of America and Fibromyalgia Network
- Hereditary Disease Foundation and Hereditary Neuropathy Foundation, Inc
- Huntington's Disease Society of America
- International Radio Surgery Association
- Intractable Childhood Epilepsy Alliance
- Jain Foundationand John Douglas French Alzheimer's Foundation
- Learning Disabilities Association of America and Les Turner ALS Foundation
- Lewy Body Dementia Association
- Lowe Syndrome Association
- Lupus Foundation of America and Lupus Research Institute
- Michael J. Fox Foundation for Parkinson's Research
- Migraine Research Foundation
- Multiple Sclerosis Association of America and Multiple Sclerosis Foundation
- Multiple System Atrophy Coalition and MUMS National Parent to Parent Network
- Brain Tumor Research and Information
- Myelin Repair Foundation and Myositis Association
- National Aphasia Association
- National Association of Hospital
- National Headache Foundation and National Health Council
- National Hospice and Palliative Care Organization and National Hydrocephalus Foundation
- National Meningitis Association and National MPS Society , Inc.
- National Multiple Sclerosis Society
- National Parkinson Foundation
- National Patient Travel Center and National Rehabilitation Information Center
- National Respite Network and Resource Center and National Reye's Syndrome Foundation
- National Shingles Foundation and National Sleep Foundation
- National Spasmodic Dysphonia Association and National Spasmodic Torticollis Association
- National Spinal Cord Injury Association and National Stroke Association
- NBIA Disorders Association and Neurofibromatosis Network
- Neuropathy Association and Nevus Outreach , Inc
- Parent Project Muscular Dystrophy and Parkinson Alliance
- Parkinson's Action Network and Parkinson's Disease Foundation
- Parkinson's Institute and Clinical Center and Parkinson's Resource Organization
- Pituitary Network Association and PMD Foundation
- Project ALS and Pseudo tumor Cerebri Support Network
- Rehabilitation International and Research Center for Stroke
- Research! America and Restless Legs Syndrome Foundation
- Spastic Paraplegia Foundation and Spina Bifida Association
- Spinal Cord Society and Spinal Muscular Atrophy Foundation
- United Brachial Plexus Network and United Cerebral Palsy
- United Leukodystrophy Foundation and United Mitochondrial Disease Foundation
- United Spinal Association and Vascular Birthmarks Foundation
- Williams Syndrome Association and Wilson Disease Association
- World Health Organization.
- The Lancet Neurology
- Alzheimer's and Dementia
- Annals of Neurology
- Brain; a journal of neurology
- Acta Neuropathologica
- Nature Reviews Neurology
- Sleep Medicine Reviews
- JAMA Neurology
- Molecular Neurodegeneration
- Brain Research Reviews
- Human Brain Mapping
- Journal of Neurology, Neurosurgery and Psychiatry
- Journal of Cerebral Blood Flow and Metabolism
- Neurobiology of Aging
- Movement Disorders
- Neurorehabilitation and Neural Repair
- Current Opinion in Neurology
- Autism Research
- Cortex; a journal devoted to the study of the nervous system and behavior
- European Neuropsychopharmacology
- Journal of Neuropathology and Experimental Neurology
- Multiple Sclerosis
- Journal of Neurodevelopmental Disorders
- Neuropathology and Applied Neurobiology
- Journal of Neurosurgery
- Brain Stimulation
- Journal of Pain
- Brain Imaging and Behavior
- Journal of Neurotrauma
- American Journal of Neuroradiology
- CNS Drugs
- Neural Plasticity
- Brain Pathology
- Cerebrovascular Diseases
- Current Alzheimer Research
- Developmental Medicine and Child Neurology
- Journal of Neurosurgery: Spine
- Alzheimer's Research and Therapy
- Aging and Disease
Top Pharmaceutical Firms:
- Merck & Co.
- Johnson & Johnson
- Gilead Sciences
- Bristol-Myers Squibb
- Novo Nordisk
- Boehringer Ingelheim
- Daiichi Sankyo
- Biogen Idec
- Merck KGaA